Structural Basis of Saccharin Derivative Inhibition of Carbonic Anhydrase IX.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
16 Nov 2023
Historique:
revised: 12 10 2023
received: 21 08 2023
medline: 29 11 2023
pubmed: 14 10 2023
entrez: 14 10 2023
Statut: ppublish

Résumé

This study explores the binding mechanisms of saccharin derivatives with human carbonic anhydrase IX (hCA IX), an antitumor drug target, with the aim of facilitating the design of potent and selective inhibitors. Through the use of crystallographic analysis, we investigate the structures of hCA IX-saccharin derivative complexes, unveiling their unique binding modes that exhibit both similarities to sulfonamides and distinct orientations of the ligand tail. Our comprehensive structural insights provide information regarding the crucial interactions between the ligands and the protein, shedding light on interactions that dictate inhibitor binding and selectivity. Through a comparative analysis of the binding modes observed in hCA II and hCA IX, isoform-specific interactions are identified, offering promising strategies for the development of isoform-selective inhibitors that specifically target tumor-associated hCA IX. The findings of this study significantly deepen our understanding of the binding mechanisms of hCA inhibitors, laying a solid foundation for the rational design of more effective inhibitors.

Identifiants

pubmed: 37837260
doi: 10.1002/cmdc.202300454
doi:

Substances chimiques

Carbonic Anhydrase IX EC 4.2.1.1
Saccharin FST467XS7D
Carbonic Anhydrases EC 4.2.1.1
Antigens, Neoplasm 0
Protein Isoforms 0
Carbonic Anhydrase Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202300454

Subventions

Organisme : European Regional Development Fund
ID : 1.1.1.2/VIAA/3/19/464
Organisme : European Regional Development Fund
ID : 1.1.1.2/VIAA/3/19/576

Informations de copyright

© 2023 Wiley-VCH GmbH.

Références

J. W. Deitmer, S. M. Theparambil, I. Ruminot, H. M. Becker, Front. Neurol. Neurosci. 2015, 8, 430.
M. A. Pinard, B. Mahon, R. McKenna, BioMed Res. Int. 2015, 2015, 453543.
C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2012, 27, 759-772.
S. K. Chia, C. C. Wykoff, P. H. Watson, C. Han, R. D. Leek, J. Pastorek, K. C. Gatter, P. Ratcliffe, A. L. Harris, J. Clin. Oncol. 2001, 19, 3660-3668.
M. Leppilampi, T. J. Karttunen, J. Kivela, M. O. Gut, S. Pastorekova, J. Pastorek, S. Parkkila, Transgenic Res. 2005, 14, 655-663.
P. Pan, M. Leppilampi, S. Pastorekova, J. Pastorek, A. Waheed, W. S. Sly, S. Parkkila, J. Physiol. 2006, 571, 319-327.
S. Chakravarty, K. K. Kannan, J. Mol. Biol. 1994, 243, 298-309.
Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, G. Mincione, C. T. Supuran, J. Med. Chem. 1999, 42, 2641-2650.
K. Köhler, A. Hillebrecht, J. Schulze Wischeler, A. Innocenti, A. Heine, C. T. Supuran, G. Klebe, Angew. Chem. Int. Ed. Engl. 2007, 46, 7697-9.
J. Ivanova, J. Leitans, M. Tanc, A. Kazaks, R. Zalubovskis, C. T. Supuran, K. Tars, Chem. Commun. (Camb.) 2015, 51, 7108-7111.
V. Alterio, M. Tanc, J. Ivanova, R. Zalubovskis, I. Vozny, S. M. Monti, A. Di Fiore, G. De Simone, C. T. Supuran, Org. Biomol. Chem. 2015, 13, 4064-4069.
J. Ivanova, F. Carta, D. Vullo, J. Leitans, A. Kazaks, K. Tars, R. Žalubovskis, C. T. Supuran, Bioorg. Med. Chem. 2017, 25, 3583-3589.
P. Guglielmi, G. Rotondi, D. Secci, A. Angeli, P. Chimenti, A. Nocentini, A. Bonardi, P. Gratteri, S. Carradori, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2020, 35, 1891-1905.
S. Bua, C. Lomelino, A. B. Murray, S. M. Osman, Z. A. ALOthman, M. Bozdag, H. A. Abdel-Aziz, W. M. Eldehna, R. McKenna, A. Nocentini, C. T. Supuran, J. Med. Chem. 2020, 63, 321-333.
J. Leitans, A. Kazaks, A. Balode, J. Ivanova, R. Zalubovskis, C. T. Supuran, K. Tars, J. Med. Chem. 2015, 58, 9004-9009.
G. De Simone, V. Alterio, C. T. Supuran, Expert Opin. Drug Discovery 2013, 8, 793-810.
J. Ivanova, B. Balode, R. Zalubovskis, J. Leitans, A. Kazaks, D. Vullo, K. Tars, C. T. Supuran, Bioorg. Med. Chem. 2017, 25, 857-863.
V. Alterio, M. Hilvo, A. Di Fiore, C. T. Supuran, P. Pan, S. Parkkila, A. Scaloni, J. Pastorek, S. Pastorekova, C. Pedone, A. Scozzafava, S. M. Monti, G. De Simone, Proc. Natl. Acad. Sci. USA 2009, 106, 16233-16238.
T. G. G. Battye, L. Kontogiannis, O. Johnson, H. R. Powell, A. G. W. Leslie, Acta Crystallogr. D Struct. Biol. 2007, 67, 271-281.
P. Evans, Acta Crystallogr D Struct Biol. 2006, 62, 72-82.
Vagin, A. Teplyakov, Acta Crystallogr D Struct Biol. 2010, 66, 22-5.
G. N. Murshudov, P. Skubák, A. A. Lebedev, N. S. Pannu, R. A. Steiner, R. A. Nicholls, M. D. Winn, F. Long, A. A. Vagin, Acta Crystallogr D Struct Biol. 2011, 67, 355-367.
P. Emsley, K. Cowtan, Acta Crystallogr D Struct Biol. 2004, 60, 2126-2132.
A. A. Lebedev, P. Young, M. N. Isupov, O. V. Moroz, A. A. Vagin, G. N. Murshudov, Acta Crystallogr D Struct Biol. 2012, 68, 431-440.

Auteurs

Janis Leitans (J)

Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.

Andris Kazaks (A)

Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.

Janis Bogans (J)

Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.

Claudiu T Supuran (CT)

NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy.

Inara Akopjana (I)

Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.

Jekaterina Ivanova (J)

Latvian Institute of Organic Synthesis, Aizkraukles 21, 1006, Riga, Latvia.

Raivis Zalubovskis (R)

Latvian Institute of Organic Synthesis, Aizkraukles 21, 1006, Riga, Latvia.
Institute of Technology of Organic Chemistry, Faculty of Materials Science and Applied Chemistry, Riga Technical University, P. Valdena iela 3, 1048, Riga, Latvia.

Kaspars Tars (K)

Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.
Faculty of Biology, University of Latvia, Jelgavas 1, Riga, 1004, Riga, Latvia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH